Warning: The NCBI web site requires JavaScript to function. more...
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.
Vander Cruyssen B, Cantaert T, Nogueira L, Clavel C, De Rycke L, Dendoven A, Sebag M, Deforce D, Vincent C, Elewaut D, Serre G, De Keyser F.
Arthritis Res Ther. 2006;8(4):R122.
Related citations
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M.
Arthritis Res Ther. 2006;8(4):R119.
Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A, Plischke H, Kellner H, Gruber R.
Ann N Y Acad Sci. 2005 Jun;1050:295-303.
Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
J Rheumatol. 2007 Aug;34(8):1658-63. Epub 2007 Jul 1.
Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
Coenen D, Verschueren P, Westhovens R, Bossuyt X.
Clin Chem. 2007 Mar;53(3):498-504. Epub 2007 Jan 26.
Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
Vander Cruyssen B, Nogueira L, Van Praet J, Deforce D, Elewaut D, Serre G, De Keyser F.
Ann Rheum Dis. 2008 Apr;67(4):542-6. Epub 2007 Jul 20.
Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F.
J Rheumatol. 2003 Jul;30(7):1451-5.
Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
Hill JA, Al-Bishri J, Gladman DD, Cairns E, Bell DA.
J Rheumatol. 2006 Nov;33(11):2115-9. Epub 2006 Aug 15.
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations.
De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F.
Ann Rheum Dis. 2004 Dec;63(12):1587-93.
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall'Aglio AC, Bianchi FB, Bakker-Jonges LE, van Venrooij WJ, Pruijn GJ, Zendman AJ.
Ann Rheum Dis. 2007 Apr;66(4):511-6. Epub 2006 Sep 19.
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.
Arthritis Rheum. 2000 Jan;43(1):155-63.
High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis.
Suzuki K, Sawada T, Murakami A, Matsui T, Tohma S, Nakazono K, Takemura M, Takasaki Y, Mimori T, Yamamoto K.
Scand J Rheumatol. 2003;32(4):197-204.
A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients.
Aflaky E, Shenavandeh S, Ashraf MJ.
Rheumatol Int. 2010 Feb;30(4):461-6. Epub 2009 Aug 12.
[Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
Yang CL, Zhou YR, Zhou F, Li J.
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Aug;27(8):1277-9. Chinese.
Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
Dewint P, Hoffman IE, Rogge S, Joos R, Union A, Dehoorne J, Delanghe J, Veys EM, De Keyser F, Elewaut D.
Rheumatology (Oxford). 2006 Feb;45(2):204-8. Epub 2005 Sep 27.
The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Orbach H, Gerli R, Shoenfeld Y.
Clin Dev Immunol. 2005 Sep;12(3):197-202.
A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.
dos Anjos LM, Pereira IA, d 'Orsi E, Seaman AP, Burlingame RW, Morato EF.
Clin Rheumatol. 2009 Feb;28(2):153-8. Epub 2008 Sep 16.
The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
Heidari B, Firouzjahi A, Heidari P, Hajian K.
Ann Saudi Med. 2009 Nov-Dec;29(6):467-70.
A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis.
van Gaalen FA, Visser H, Huizinga TW.
Ann Rheum Dis. 2005 Oct;64(10):1510-2. Epub 2005 Mar 30.
Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis.
Lutteri L, Malaise M, Chapelle JP.
Clin Chim Acta. 2007 Nov-Dec;386(1-2):76-81. Epub 2007 Aug 16.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on